Vanguard Global Advisers
ACET icon

Vanguard Global Advisers’s Adicet Bio ACET Stock Holding History

Vanguard Global Advisers’s Portfolio ACET Stock Details ACET Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$45.1K Hold
5,221
– – ﹤0.01% 3107
2026
Q1 		$35.6K Buy
+5,221
New +$39.1K ﹤0.01% 3148

Other funds holding ACET

RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
SCM
Stonepine Capital Management Bend, Oregon $214M AUM 88.6% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $38.9B AUM 28.51% 1-Year Est. Return
SSA
Schonfeld Strategic Advisors New York $27.9B AUM 51.19% 1-Year Est. Return

Vanguard Global Advisers's ACET Position: Q2 2026 in Review

Vanguard Global Advisers held its Adicet Bio (ACET) position steady in Q2 2026 at 5,221 shares worth $45.1K. The position accounts for ﹤0.01% of the portfolio, ranked #3107.

Vanguard Global Advisers first reported a position in ACET in Q1 2026 and has held it in 2 quarters since. 56 funds tracked by Wall St. Rank hold ACET as of Q2 2026.

  • Vanguard Global Advisers held 5,221 shares of Adicet Bio worth $45.1K as of Q2 2026.
  • Vanguard Global Advisers left its Adicet Bio share count unchanged in Q2 2026.
  • Adicet Bio made up ﹤0.01% of Vanguard Global Advisers's portfolio in Q2 2026, its #3107 holding.
  • Vanguard Global Advisers first reported a position in Adicet Bio in Q1 2026 and has held it in 2 quarters since.
  • 56 funds tracked by Wall St. Rank held Adicet Bio as of Q2 2026.

Based on Vanguard Global Advisers's 13F filing for Q2 2026, filed 13 Aug 2026.